Brantussin Dm
NDC Package 71321-700-16

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Brantussin Dm is a . Marketed by Brandywine Pharmaceuticals, Llc, this product is identified by NDC 71321-700 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
71321-700-16
Package Description
473 mL in 1 BOTTLE
Product Code
71321-700
11-Digit Billing Format
71321070016
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
473 ML

Clinical Specifications

Proprietary Name
Brantussin Dm
Dosage Form
-

Regulatory & Marketing

Labeler Name
Brandywine Pharmaceuticals, Llc
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
10-14-2022
End Marketing Date
01-07-2026
Listing Expiration
01-07-2026
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 71321-700-16 identifies a specific commercial package of 473 ml in 1 bottle of Brantussin Dm, labeled by Brandywine Pharmaceuticals, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Brandywine Pharmaceuticals, Llc on October 14, 2022. The current certification is valid through January 07, 2026.

How is this Brandywine Pharmaceuticals, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 71321070016. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 473 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
71321-700-16
11-Digit CMS (5-4-2)
71321-0700-16

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.